A Competing Risks Model in Early Screening for Preeclampsia

Publisher： Karger

E-ISSN： 1421-9964|32|3|171-178

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.32, Iss.3, 2012-07, pp. : 171-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 1, 2012-08 ,pp. : 8-15

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 1, 2014-05 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-05 ,pp. : 240-248

Karger

Access to resources Recommend Favorite

Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 1, 2014-06 ,pp. : 18-27

Karger

Access to resources Recommend Favorite

Microarray Screening for Novel Preeclampsia Biomarker Candidates

By  

Fetal Diagnosis and Therapy, Vol. 31, Iss. 3, 2012-03 ,pp. : 147-153

Karger

Access to resources Recommend Favorite